Antibody response to influenza vaccine in adults vaccinated with identical vaccine strains in consecutive years
Corresponding Author
Shigeki Nabeshima
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
General Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonanku, Fukuoka 814-0180, Japan.===Search for more papers by this authorKenichiro Kashiwagi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorMasayuki Murata
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorYoko Kanamoto
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorNorihiro Furusyo
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Environmental Medicine and Infectious Diseases, Internal Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Search for more papers by this authorJun Hayashi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Environmental Medicine and Infectious Diseases, Internal Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Search for more papers by this authorCorresponding Author
Shigeki Nabeshima
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
General Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonanku, Fukuoka 814-0180, Japan.===Search for more papers by this authorKenichiro Kashiwagi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorMasayuki Murata
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorYoko Kanamoto
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Search for more papers by this authorNorihiro Furusyo
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Environmental Medicine and Infectious Diseases, Internal Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Search for more papers by this authorJun Hayashi
Department of General Medicine, Kyushu University Hospital, Fukuoka, Japan
Environmental Medicine and Infectious Diseases, Internal Medicine, Faculty of Medical Sciences, Kyushu University, Fukuoka, Japan
Search for more papers by this authorAbstract
Fifty seven hospital workers received influenza vaccine in November 2003, and the serum HI antibody titer was determined before, 2 and 4 weeks after the vaccination. Thirty seven were vaccinated in November, 2002 consecutively (the repeated vaccination group), and the remaining 20 had not been vaccinated in the previous year (the single vaccination group). Six of the repeated vaccination group received both influenza and hepatitis B vaccination in September, 2004 and the antibody responses were examined 2 weeks later. Two and four weeks after the 2003-vaccination, the HI antibody titers to A/H1N1, A/H3N2, and B in the repeated vaccination group were significantly lower than in the single vaccination group (P < 0.05). This phenomenon had no relation to the pre-vaccination HI antibody titer. The antibody response was low to repeated influenza vaccination, but normal to hepatitis B vaccine in six subjects who had a second vaccination in 2004, showing that this depressed response was influenza-specific. These results suggest that the decreased HI antibody response to repeated influenza vaccination was affected mainly by the previous vaccination per se rather than by the pre-existing antibody titer. J. Med. Virol. 79:320–325, 2007. © 2007 Wiley-Liss, Inc.
REFERENCES
- Ahmed AE, Nicholson KG, Nguyen-Van-Tam JS. 1995. Reduction in mortality associated with influenza vaccine during 1989-90 epidemic. Lancet 346: 591–595.
- Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. 1998. The plea against annual influenza vaccination? ‘The Hoskins' Paradox’ revisited. Vaccine 16: 1929–1932.
- Beyer WE, de Bruijn IA, Palache AM, Westendorp RG, Osterhaus AD. 1999. Protection against influenza after annually repeated vaccination: A meta-analysis of serologic and field studies. Arch Intern Med 159: 182–188.
- Cox RJ, Brokstad KA, Zuckerman MA, Wood JM, Haaheim LR, Oxford JS. 1994. An early humoral immune response in peripheral blood following parenteral inactivated influenza vaccination. Vaccine 12: 993–999.
- de Bruijn IA, Remarque EJ, Beyer WE, le Cessie S, Masurel N, Ligthart GJ. 1997. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 15: 1323–1329.
- de Bruijn IA, Remarque EJ, Jol-van der Zijde CM, van Tol MJ, Westendorp RG, Knook DL. 1999. Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. J Infect Dis 179: 31–36.
- Demicheli V, Jefferson T, Rivetti D, Deeks J. 2000. Prevention and early treatment of influenza in healthy adults. Vaccine 18: 957–1030.
- Ghendon Y. 1990. The immune response to influenza vaccines. Acta Virol 34: 295–304.
- Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA. 1995. The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med 123: 518–527.
- Gross PA, Denning CR, Gaerlan PF, Bonelli J, Bernius M, Dran S, Monk G, Vassallo M, Quinnan GV, Jr., Levandowski R, Cataruozolo PE, Wallenstein S. 1996. Annual influenza vaccination: Immune response in patients over 10 years. Vaccine 14: 1280–1284.
- Hannoun C, Megas F, Piercy J. 2004. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 103: 133–138.
- Hobson D, Curry RL, Beare AS, Ward-Gardner A. 1972. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J Hyg (Lond) 70: 767–777.
- Hoskins TW, Davies JR, Allchin A, Miller CL, Pollock TM. 1973. Controlled trial of inactivated influenza vaccine containing the a-Hong Kong strain during an outbreak of influenza due to the a-England-42-72 strain. Lancet 2: 116–120.
- Hoskins TW, Davies JR, Smith AJ, Allchin A, Miller CL, Pollock TM. 1976. Influenza at Christ's Hospital: March, 1974. Lancet 1: 105–108.
- Hoskins TW, Davies JR, Smith AJ, Miller CL, Allchin A. 1979. Assessment of inactivated influenza-A vaccine after three outbreaks of influenza A at Christ's Hospital. Lancet 1: 33–35.
- Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. 2005. Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 366: 1165–1174.
- Keitel WA, Cate TR, Couch RB. 1988. Efficacy of sequential annual vaccination with inactivated influenza virus vaccine. Am J Epidemiol 127: 353–364.
- Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR. 1997. Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 15: 1114–1122.
- Kunzel W, Glathe H, Engelmann H, Van Hoecke C. 1996. Kinetics of humoral antibody response to trivalent inactivated split influenza vaccine in subjects previously vaccinated or vaccinated for the first time. Vaccine 14: 1108–1110.
- Masurel N, Laufer J. 1984. A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: Immunogenicity, clinical reactions and protection. J Hyg (Lond) 92: 263–276.
- Potter CW, Oxford JS. 1979. Determinants of immunity to influenza infection in man. Br Med Bull 35: 69–75.
- Powers RD, Hayden FG, Samuelson J, Gwaltney JM, Jr. 1984. Immune response of adults to sequential influenza vaccination. J Med Virol 14: 169–175.
- Pyhala R, Alanko S, Forsten T, Haapa K, Kinnunen L, Jaaskivi M, Visakorpi R, Valle M. 1994a. Early kinetics of antibody response to inactivated influenza vaccine. Clin Diagn Virol 1: 271–278.
- Pyhala R, Kumpulainen V, Alanko S, Forsten T. 1994b. HI antibody kinetics in adult volunteers immunized repeatedly with inactivated trivalent influenza vaccine in 1990-1992. Vaccine 12: 947–952.
- Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, Tashiro M. 2001. The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889–896.
-
Remarque EJ,
de Bruijn IA,
Boersma WJ,
Masurel N,
Ligthart GJ.
1998.
Altered antibody response to influenza H1N1 vaccine in healthy elderly people as determined by HI, ELISA, and neutralization assay.
J Med Virol
55:
82–87.
10.1002/(SICI)1096-9071(199805)55:1<82::AID-JMV13>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- Voordouw AC, Sturkenboom MC, Dieleman JP, Stijnen T, Smith DJ, van der Lei J, Stricker BH. 2004. Annual revaccination against influenza and mortality risk in community-dwelling elderly persons. Jama 292: 2089–2095.
- Zimmerman RK, Middleton DB. 2005. Vaccines for persons at high risk due to medical conditions, occupation, environment, or lifestyle, 2005. J Fam Pract 54: S27–S36.